Int J Circumpolar Health by Hueffer, Karsten et al.
Zoonotic infections in Alaska: disease
prevalence, potential impact of climate
change and recommended actions for
earlier disease detection, research,
prevention and control
Karsten Hueffer1, Alan J. Parkinson2*, Robert Gerlach3 and
James Berner4
1Department of Biology and Wildlife, Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks,
AK, USA; 2Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases,
Centers for Disease Control and Prevention, Anchorage, AK, USA; 3Office of the State Veterinarian, Alaska
Division of Environmental Health, Anchorage, AK, USA; 4Community Health Services, Alaska Native Tribal
Health Consortium, Anchorage, AK, USA
Over the last 60 years, Alaska’s mean annual temperature has increased by 1.68C, more than twice the rate
of the rest of the United States. As a result, climate change impacts are more pronounced here than in other
regions of the United States. Warmer temperatures may allow some infected host animals to survive winters
in larger numbers, increase their population and expand their range of habitation thus increasing the
opportunity for transmission of infection to humans. Subsistence hunting and gathering activities may
place rural residents of Alaska at a greater risk of acquiring zoonotic infections than urban residents.
Known zoonotic diseases that occur in Alaska include brucellosis, toxoplasmosis, trichinellosis, giardiasis/
cryptosporidiosis, echinococcosis, rabies and tularemia. Actions for early disease detection, research and
prevention and control include: (1) determining baseline levels of infection and disease in both humans and
host animals; (2) conducting more research to understand the ecology of infection in the Arctic environment;
(3) improving active and passive surveillance systems for infection and disease in humans and animals; (4)
improving outreach, education and communication on climate-sensitive infectious diseases at the community,
health and animal care provider levels; and (5) improving coordination between public health and animal
health agencies, universities and tribal health organisations.
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O
ver the past 50 years, Alaska’s average annual
temperature has increased by 1.68C which is
more than twice the rate of the rest of the
United States. Observed effects include an increase in
precipitation, and length of frost-free growing season,
a decrease in sea ice, glacial and snow cover, an increase
in sea level, an increase in river outflow, changes in plant
and vegetation cover with an increase in shrubs and
vascular plants and change of tundra and permafrost to a
wetlands ecology, and a decrease in permafrost in some
regions with consequential damage to built infrastructure
(1,2). These changes are of concern to those residents of
Alaska who depend on the local environment for water,
key subsistence food wildlife species, such as terrestrial
and marine mammals (caribou, reindeer, moose, musk-
oxen seal and walrus), fish, water fowl and plants) for
their health and cultural well-being. Climate and weather
also affect the distribution, and risk of many helminthic,
bacterial, viral and protozoan parasitic diseases as well as
insect and ectoparasitic vectors affecting both animals
and humans. However, the interaction of hosts, vectors,
pathogens and the environment are poorly understood in
the Arctic (3). While most pathogens are species-specific,
that is, restricted to either certain animals or humans,
some, i.e. the zoonoses, are transmissible from animals
to humans, often through close contact with animals or
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food products derived from these animals. Zoonotic
infectious diseases may be climate sensitive. Warmer tem-
peratures may allow a parasite to survive in the environ-
ment for longer periods, increase an insect replication
cycle, allow an infected host animal species to survive
winters in larger numbers, increase in population and
expand their range of habitation, thus increasing the
opportunity for transmission of the infection to humans.
Subsistence hunting, gathering, food preparation and
preservation methods may also place people at risk for
acquiring zoonotic infections. Known zoonotic diseases
that occur in Alaska include brucellosis, toxoplasmosis,
trichinellosis, giardiasis, cryptosporidiosis echinococco-
sis, rabies and tularemia. This article reviews what is
known about the potentially climate-sensitive zoonotic
infectious diseases of concern in Alaska, identifies com-
mon gaps in our knowledge of these pathogens and
recommends actions that will begin to address earlier
disease detection, research and prevention and control
of these potential zoonotic disease threats in the con-
text of a changing Alaskan climate.
Brucellosis
Brucellosis is a systemic disease caused by a number of
different species of bacterium (Brucella) that may result
in abortion, infertility and chronic infections in animals.
The bacterium can be passed from domestic and wild
animals to humans via ingestion of raw milk products,
exposure to fluids and tissues of infected animals,
through cuts or abraded skin and exposure by infectious
aerosols via lungs and eyes. There are 10 species of
Brucella recognised in animals and some include different
strains or biovars. Three main species are known to
cause illness in humans: Brucella abortus (from cattle and
bison), B. melitensis (from sheep and goats) and B. suis
(from pigs, caribou and reindeer). B. suis biovar IV have
been found in caribou and reindeer (4). Eating raw,
undercooked, dried, smoked or frozen meat or organ
tissue (liver, kidney, bone marrow) can expose people to
the infection. Brucellosis is a systemic bacterial disease
of acute or insidious onset with continued intermittent
or irregular fever of variable duration with headache,
weakness, sweating, chills, joint pain and weight loss.
The first human case of B. suis biovar IV was detected
in Alaska in 1959 and was linked to the consumption of
raw caribou (5). Since then, human infections have been
linked to the consumption or processing of raw caribou
meat, and infection has been shown to be endemic in
many caribou and reindeer herds across Alaska and
northern Canada (68). This is in contrast to other parts
of the United States, where the most common route of
transmission is through the consumption of raw dairy
products and meat. However, there is little data on the
prevalence of brucellosis in humans or wildlife in Alaska.
More contemporary data on the prevalence of brucellosis
in humans and wildlife in Alaska are needed. Other
Brucella spp. can also infect other land and marine
mammals (9,10). While human infections caused by a
marine Brucella, found in seals (B. pinnipedialis), has also
been documented (11), evidence for the direct transmis-
sion from seals to humans has yet to be established, as is
the risk to humans who depend on marine mammals as a
food source. In Alaska, human Brucella infections are
reportable conditions to the State of Alaska, Division
of Public Health, Section of Epidemiology (SOE) and
infections in wildlife, domestic herds and other animals
are reported to the Office of the State Veterinarian
(OSV). Since 1973, there have been 17 reported human
cases in Alaska (12,13). Reporting in animals is compli-
cated by the absence of standardised diagnostic tests for
different species of animals. Current serologic tests are
not species-specific and cross-react with other bacteria
and Brucella spp underscoring the need for the develop-
ment of standardised, validated Brucella specific tests.
Efforts are underway to establish and validate simple
filter paper blood collection systems that can be used
by hunters and wildlife biologist for wildlife in the field
(14) for the detection of Brucella antibody using serology.
Preventive measures include vaccination of domestic
livestock (cattle, reindeer), community education recom-
mending fully cooking meat, cleaning of surfaces and
tools with a water/bleach solution after contact with
meat. Hunters should take special precautions when
butchering animals in the field, such as careful examina-
tion of the animal carcass for abnormalities suggesting
brucellosis, wearing gloves and glasses to avoid being
infected by animal blood through cuts and abrasions on
hands or contact with the eyes or mouth.
It is unclear if or how climate change may influence
brucellosis rates in animals or people. A warming Arctic
may change the range of many animals, contribute to the
greater survival of infected animals during winter, which
in turn could either increase or decrease herd densities
and contribute to greater comingling of species, thus
increasing the potential for greater interspecies transmis-
sion and transmission to humans. Conversely, changes
in weather patterns (more snow and ice cover) may
limit access to important food sources, affecting animal
nutrition resulting in decreased herd densities, fewer
animals to harvest and reduced opportunities for human
infection with Brucella.
Toxoplasmosis
Toxoplasmosis is caused by infection with Toxoplasma
gondii, a widespread protozoan parasite of mammals and
birds. Members of the cat family are the only known
definitive host of T. gondii. However, the asexual encysted
stage can be found in muscle tissues of other animals and
can serve as the main reservoir of infection in cat-free
areas. Humans become infected by ingesting raw or
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insufficiently cooked meat or foods that have come
into contact with viable oocysts from soil, or items that
have come into contact with cat faeces (unwashed vege-
tables). Typically, the infection in humans is mild, with
fever and lymphadenitis or can be asymptomatic. In
immune-compromised individuals, more severe complica-
tions such as encephalitis or acute toxoplasmic chorior-
etinitis may occur. However, the main health concern is in
pregnant women where tachyzoites can migrate transpla-
centally resulting in foetal morbidity or mortality.
A serosurvey was conducted in the 1960s and 70s
which showed that 15% of Alaska Natives had anti-
bodies to T. gondii, a rate similar to that found in the
United States (15). This contrasts with a more recent
study conducted among the Inuit of Nunavik which
showed a seroprevalence of 60%, almost three times the
North American average prevalence (16). Because felid
hosts are rare in this region, it is likely that the source of
infection is related to the eating of raw, dried or under-
cooked meat (caribou, land or waterfowl or seal (17)).
The recent discovery of Toxoplasma in polar bears and
Arctic foxes in Svalbard in the absence of a definitive host
also highlights the existence of alternative transmission
routes. (18). It has been hypothesised that Toxoplasma in
animals in this region may have been introduced to this
region by migratory birds. The prevalence of Toxoplasma
in polar bears in Svalbard, the Barents Sea Region and
Eastern Greenland areas has doubled in the last decade
(now 46%), and detection in Ring Seals for the first time
highlights the role of predatorprey cycles as a mechan-
ism of maintaining this infection in this region, and
the risk of infection in human populations that rely on
marine mammals for food (19).
In the United States, toxoplasmosis in humans is
neither a national nor a state-mandated reportable
condition; therefore detailed statistics about the disease
in Alaska are limited. Seroprevalence studies in humans
may provide information about the disease exposure in
Alaska.
The disease in wildlife domestic herd and other animals
is reportable to the OSV. However, better surveillance data
for Toxoplasma in wildlife species is needed to understand
the ecology of the disease in Alaska. Two diagnostic tests
are available for T. gondii that can be used in various
species of animals  a molecular method (multiplex PCR)
and a multi-species enzyme immunoassay (ELISA) that
detects its antibodies in blood or tissue fluid. An absorb-
ent filter paper method to collect blood from animals
under field conditions for the diagnosis of T. gondii in
wildlife is being developed (20,21). This will simplify
blood collection under Arctic conditions and facilitate
sample collection by hunters.
Measures to prevent human infection include: fully
cooking meat, washing fruits and vegetables, cleaning
food preparation surfaces with a water/bleach solution
after contact with meat. Hunters and trappers should
take special precautions when hunting or trapping lynx,
as lynx serve as the only known Alaska wildlife source
of Toxoplasma oocysts. There is a need for more public
education, particularly among pregnant women in Arctic
regions to alert people to the fact that this is a food-borne
disease, and is not always associated with cats (22).
Since testing began on samples collected from Alaska
wildlife in the 1970s, antibodies against T. gondii have
been detected in a wide variety of species, including lynx,
black bears, grizzly bears, wolves and herbivores (2325).
Among marine mammals, antibodies have been detected
in walrus, Steller sea lions, harbor, ringed, spotted and
bearded seals (26).
While there is no evidence yet of increased transmission
of toxoplasma associated with climate change effects, there
are climate and weather effects that may either increase
or decrease the survival of parasites in the environment,
increase or decrease the abundance of host species, and
may result in the emergence of disease at altered interfaces
among wildlife, domestic animals and human popula-
tions. For example, higher humidity and warmer soil
temperatures may increase the rate of sporulation and
survival of oocysts (27). Increased storm events pre-
dicted with climate change are likely to result in damage
to community water intake systems, increased runoff
into rivers or other fresh water sources and increased
chances of contamination of community water supplies
with oocycts (28). Storm related runoff also increases
water turbidity, frequently compromising water purifica-
tion filter systems. This together with damage to water and
sanitation infrastructure caused by melting permafrost
potentially increases the chance of water borne outbreaks
of toxoplasmosis in these communities. The dramatic
loss of Arctic sea ice may result in animal crowding on
land and remaining sea ice, increased mortality and
scavenging that may increase the transmission of oocysts
to carnivores, marine shellfish and thence to other marine
mammals, whales, walrus, otters and seals, which are
all important substance species for Alaska Natives (29).
Trichinellosis
Trichinellosis is caused by any species of Trichinella, an
intestinal roundworm whose larvae migrate and become
encapsulated in muscle tissue of domestic (commonly
pigs) or wild animals. In the Arctic, bear and walrus meat
are the main sources of human infection. The most
common species in Arctic regions are T. nativa and
Trichinella genotype T6 which, unlike other Trichinella
species, survives freezing. Infection in humans occurs
following consumption of raw or undercooked meat
containing viable encysted larvae. Illness in humans is
variable ranging from asymptomatic infection to a rarely
fatal disease, depending on the number of larvae ingested.
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The most frequent reports of human trichinellosis in
Alaska are multi-person outbreaks that result from more
than one person consuming the same meal of under-
cooked bear, walrus or seal meat (30). In Alaska, from
1974 to 1994, 203 cases of Trichinella were reported to
the SOE. Of the 34 outbreaks documented, 20 (59%)
were caused by the consumption of bear meat, 13 (38%)
from walrus meat and in one case (3%) from the
consumption of either walrus or seal meat. Most out-
breaks of trichinellosis in Canada have been due to
Trichinella nativa or Trichinella genotype T6 which is
generally found in game animals such as black bears,
grizzly bears, polar bears and walrus (31,32) In Alaska,
Trichinella infections are reportable to SOE and the OSV.
Trichinella can be detected in muscle tissue by laboratory
methods that use artificial digestion of muscle tissues
followed by microscopy or DNA analysis by PCR.
Microscopy introduces the possibility of false negative
result if small numbers of larvae are present. Antibodies
to Trichinella can be detected by ELISA. However,
antibody cross-reactivity with antigens of other parasites
may give false positive results, underscoring the need for
more species-specific antibody assays (33).
Prevention messages should stress that T. nativa in
bear and walrus meat is cold resistant and that meat
should be cooked to a temperature of at least 1608F.
Smoking, salting, fermenting or drying meat are not
reliable methods for killing the parasite (34). Enhanced
surveillance for Trichinella in subsistence food animal
populations in Alaska would help inform prevention
efforts. A model programme exists in Nunavik where
walrus harvested by hunters is tested before consump-
tion (35). However, this requires a sustainable source of
funding, a system for rapid testing and rapid commu-
nication of results back to the community.
Climate change may affect the migration of terrestrial
or marine mammals. This could result in changes in
the availability of food, quality and species composition
of food, and increase in contact between terrestrial and
marine mammals. Loss of sea ice could interfere with
resting, feeding and breeding of marine mammals (29).
The decline of summer sea ice has already resulted in
large ‘‘haul-outs’’ of walruses on beaches in northwestern
Alaska. Dead animals on beaches or on ice packs or
at the bottom of the sea and may contribute to the
transmission of Trichinella to other land or marine
scavengers and carnivores (29,36). There is no current
evidence that climate change has contributed to an
increase in Trichinella prevalence in Alaskan wildlife
populations.
Giardiasis and cryptosporidiosis
Giardiasis is caused by infection with Giardia protozoa
(Giardia intestinalis), and in humans it is typically char-
acterised by self-limited diarrhea (37). Cryptosporidiosis,
also a self-limited diarrheal disease in humans, is caused
mainly by infection with Cryptosporidium parvum or C.
hominis. Fatalities can occur in widespread outbreaks
where the elderly or immunosuppressed are infected.
Both Giardia and Cryptosporidium protozoa are wide-
spread in the environment. While Cryptosporidium
infections are often associated with the consumption
of untreated surface water contaminated with animal
faeces, Giardia is most commonly associated with the
ingestion of water contaminated by human faeces. Re-
cently characterised molecular variation among Giardia
and Cryptosporidium parasites has allowed genotypes
to be divided into assemblages, which are grouped by
degree of similarity (38,39). Data suggest that among
Giardia protozoa, certain assemblages are more likely to
be associated with specific animal species, and parasites
found in humans are more likely to align with assem-
blages consisting of isolates from other humans, as
opposed to parasites from non-human animal species.
This might mean that person-to-person transmission,
an acknowledged but not typically emphasised route,
is more common than previously expected, as opposed
to transmission being primarily from a zoonotic or
environmental source.
In Alaska, human cases of both Giardia and
Cryptosporidium are reportable to the SOE. From
20012010, 1,042 human cases of giardiasis were reported,
and annual rates of giardiasis in Alaska are routinely
higher than in the rest of the United States (37). The
number of reported giardiasis cases underestimates
the true incidence of disease by an unknown amount,
as only laboratory-confirmed infections are typically
reported to SOE and empiric treatment of suspected
cases based on clinical presentation are not usually
reported to SOE.
In contrast, human disease caused by Cryptosporidium
is rare and ranges from 0 to 4 cases per year in Alaska.
However, it is also likely that it is under-diagnosed. The
State Public Health Laboratory currently conducts testing
of stools. New serologic tests are becoming available that
could be used to determine seroprevalence of exposure at
the community level.
Wildlife and domestic animal disease caused by
Giardia or Cryptosporidium are reportable to the OSV
but is most likely under-reported by practitioners un-
familiar with regulation and animals are often treated
clinically rather than diagnoses due to financial limita-
tions. The prevalence of Cryptosporidium and Giardia
spp. appears to be widespread among wildlife in Alaska
(39,40). Either boiling or filtering untreated surface water
before drinking can prevent giardiasis and cryptospor-
idiosis. It is important to protect public water supplies
against contamination with animal or human faeces
and ensure adequate filtration of community water
supplies.
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Giardiasis and cryptosporidiosis may be sensitive to
climate change. Higher temperatures and a changing
environment may favour the migration of host animals
northward into regions where disease has yet to be
established. In Alaska, the tree line has moved northward
as have beaver and muskrat populations, potentially
exposing human residents of these regions to new diseases
such as Giardia or other diseases carried by insect vectors
associated with these animals (41). Climate change may
bring precipitation and increased soil moisture, which
may increase pathogen survivability. Increased runoff
into drinking and recreational water sources may increase
the concentration of organisms and potential for trans-
mission. Increased storm events may result in damage
to community water intake systems, increased runoff
into rivers or other fresh water sources, increasing the
chance of contamination of community water supplies
(29). Storm related runoff also increases water turbidly,
frequently compromising water purification filter systems.
This together with damage to water and sanitation infra-
structure caused by melting permafrost potentially in-
creases the chance of water borne outbreaks of giardiasis
and cryptosporidiosis in these communities.
Echinococcosis*cystic and alveolar hydatid
disease
Echinococcosis granulosis has worldwide distribution
(42) and there are two recognised biotypes: northern (or
sylvatic) and the domestic biotype. Northern strain cystic
hydatid disease is caused by Echinococcus granulosus
which maintains a cycle that includes an adult cestode
stage in the definitive host such as a wolf, coyote, fox
or dog, and a larval cestode stage in an intermediate host
such as a moose, deer, caribou, reindeer but does not
cross-infect domestic livestock (43). Humans usually
acquire the infection via exposure to eggs that were
shed in canid faeces and are an accidental host (43).
The infection caused by the northern biotype in humans
is relatively benign (44), developing over many years
and resulting in cyst formations in the liver and lungs
(42,44). In contrast, human alveolar hydatid disease
caused by Echinococcus multilocularis is associated
with a much higher mortality rate than cystic hydatid
disease. Alveolar hydatid disease has a distribution
throughout the northern hemisphere (42) and is endemic
in south-central Canada and the northern Midwestern
United States (45). Echinococcus multilocularis maintains
a cycle that includes an adult cestode stage in the
definitive host, commonly a fox, wolf, coyote or dog,
and a larval cestode stage in an intermediate host such
as a vole or a deer mouse.
In Alaska, cases of human disease caused by
Echinococcus species (both granulosus and multilocularis)
are reportable to the SOE. Since the 1950s, over 300
cases of echinococcosis were reported (46). Since 1990,
only eight cases of E. granulosus and no cases of E.
multilocularis have been reported (46). Because cases
may be asymptomatic, the actual number of infections
could be higher. In Alaska, there were 193 (mostly
Alaska Native) cases diagnosed up until 1980, and various
reports document similar numbers from various regions
of northern Canada (47).
In 1990, high human rates of alveolar hydatid disease
were reported from western Alaska (especially Saint
Lawrence Island). In these villages, the annual incidence
of diagnosis ranges from 7 to 98/100,000 (48). Between
1951 and 1991, 70 cases of alveolar hydatid disease
were diagnosed mostly from Northwestern Alaska and
in Alaska Natives (49).
More specific serologic tests for diagnosis and sero-
prevalence studies are needed. New molecular typing
methods are being developed (50), but currently little is
known about the significance of molecular variation.
Dog treatment programmes in the 1980s significantly
reduced the prevalence in dogs (51). However, many
of these programmes have since been discontinued. An
assessment of these remaining programmes is needed to
improve educational outreach, community based control
programmes and guidelines for dealing with dogs. Pre-
valence of the domestic biotypes in the domestic livestock
populations is also unknown. A survey of infection rates
in animal reservoirs is needed in order to identify
geographical distributions and to lay a baseline for future
climate related fluctuations in reservoir populations. This
would require local laboratory capacity, mapping re-
sources, trained technical staff and funding.
Prevention measures include: the education of hunters
and trappers to use gloves, hand washing and to practice
good food hygiene and appropriately dispose of viscera;
education of community members on modes of transmis-
sion and good personal hygiene; ensure communities
practice proper dog control (i.e. keeping dog lots
away from the community) and institute dog treatment
(Praziquantel) programmes.
E. granulosis and E. multilocularis are already present
in the Arctic and their distribution seems to be dependent
on the presence of the appropriate host. A warming
Arctic may increase egg survival in the environment,
alter distribution and abundance of intermediate hosts
and alter interfaces among wildlife, domestic animals and
people (29).
Rabies
Rabies is an acute viral infection causing progressive viral
encephalomyelitis that is nearly always fatal. Rabies is
caused by RNA viruses in the family Rhabdoviridae,
genus Lyssavirus. Transmission is most often through
saliva via a bite from an infected animal. Mammals
are the natural hosts of rabies. Reservoirs consist of the
Carnivora (canids, skunks, raccoons, mongooses) and
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Chiroptera (bats). Dogs are the main source of infection
for humans, although wildlife is also an important source
of infection in developed countries where dog rabies has
been mostly eliminated. Rabies is enzootic among the
fox populations of northern and western Alaska, with
periodic epizootics documented every 35 years following
variation in prey and predator populations (52). The last
epizootic in Alaska was in 200607. Although rabies has
been documented in animals every month of the year,
most cases are usually reported during early fall through
early spring. In early spring, Arctic foxes tend to move
inland off the sea ice, increasing the likelihood of coming
into contact with domestic animals or humans. Dogs can
readily serve as a transmission vehicle of the rabies virus
from wildlife to humans; therefore, it is especially critical
during these seasons to ensure that adequate rabies
prevention and control measures are in place. The
prevalence of rabies in wildlife reservoirs is unknown
and reducing rabies in the Alaskan fox populations is
not yet feasible. Therefore, the mainstays of preventing
human rabies cases are the use of a non-veterinarian
lay vaccinator programme in rural areas, public edu-
cation of the risk in the wildlife (fox) population,
vaccination of domestic animals against rabies and
prompt administration of rabies post-exposure pro-
phylaxis to persons potentially exposed to the rabies
virus (53).
Human cases and potential exposures are reportable to
the SOE which are promptly investigated. Three human
cases have been reported since 1914, but none since 1942.
Between 15 and 50 cases in wildlife are reported each
year. Many gaps in our understanding of this disease
remain, and areas requiring further investigation include:
(1) factors influencing epidemics in animals (epizootics);
(2) the lack of evidence of animal rabies in the interior of
Alaska; (3) the ecology and interaction between Arctic
and Red foxes; and (4) the potential impact of climate
change on disease and the role of species incursions (red
foxes and bats). While standard fluorescent antibody
microscopy diagnostics are available at Alaska State
Virology Laboratory in Fairbanks, a key challenge is
the lack of the full range of in-state veterinary diagnos-
tics. Some surveillance is currently underway by the
Alaska Department of Fish & Game and the University
of Alaska Fairbanks using the direct rapid immunohis-
tochemical test (DRIT). However, funding for surveil-
lance of animal rabies is currently dependent on
investigator-driven research grants.
Loss of sea ice due to climate change may result in
greater contact between foxes and domestic animals.
It will also restrict movement of Arctic foxes. A warming
Arctic is also expected to increase the range of the
Red fox into Arctic fox territory, and the potential
northern expansion of bats into southeastern Alaska
(54). The exact consequences of these changes in the
ecology of these reservoir hosts are currently not well
understood (3,53,54).
Tularemia
Tularemia results from infection with the bacterium
Francisella tularensis through the bite of an arthropod
or through an open wound while handling contaminated
water or animal carcasses, from the inhalation of dust
from contaminated hay or soil, or from the consumption
of inadequately cooked meat of infected animals. Person-
to-person transmission has not been described. After a
35-day incubation period (range 110 days), any of five
different presentations of tularemia may develop depend-
ing upon the portal of entry: (1) Ulceroglandular,
characterised by a painful skin lesion or ulceration with
subsequent acutely enlarged and tender regional lymph
nodes; the most common form. (2) Glandular with
acutely enlarged and tender lymph nodes without skin
lesions. (3) Oropharyngeal, severe exudative pharyngitis,
sometimes accompanied by vomiting, abdominal pain
or diarrhoea resulting from ingestion of the bacteria. (4)
Oculoglandular severe conjunctivitis with regional lymph
node involvement; the most rare form, (5) Typhoidal
tularemia with pneumonia, septicaemia and hepatosple-
nomegaly; the most severe form. Tularemia occurs
throughout North America and northern Europe, China
and Japan. Reservoirs include wild or feral animals:
rabbits, hares, voles, muskrats, beavers and some domes-
tic animals. A rodentmosquito cycle has been described
(F. tularensis sub-species holarctica) in Scandinavia and
Russia (55). In Alaska, both F. tularensis sub-species
holarctica and the more virulent subspecies tularensis
have been isolated from patients (56). Humans are
infected via the bite of an arthropod (commonly ticks
in North America and mosquitos in northern Europe) or
by inoculation through the skin, conjunctiva orophar-
yngeal mucosa via contaminated water, blood, and tissue
while handling infected carcasses. Other routes include
the ingestion of contaminated meat from infected animals
or by the inhalation of contaminated dust from soil,
grain, hay or animal pelts.
In Alaska, human cases are reportable to the SOE
and animal and wildlife cases to the OSV (57). From
19462009, there have been 29 human cases of tularemia
reported to the SOE. Since 2001, there have been five
human cases. Four of the five resided in and were infected
in Alaska. The majority of cases occurred in the summer
and were likely to be related to time spent outdoors and
exposure to vectors. There is no surveillance in animal
or insect vector reservoirs in Alaska and cases in
domestic animals are likely under-reported as animals
are often treated empirically. There is a need to increase
surveillance of disease in wildlife to be able to monitor
the impact of climate change on epizootics events of
tularemia.
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Table I. Common gaps in knowledge among pathogens, recommendations for actions and technology needed to address prevention
and control of these zoonotic threats in the context of a changing Alaskan climate
Agent Gaps Actions Needed Technology Needed
Brucella Recent baseline levels of infection
and disease in humans and wildlife
unknown.
Conduct seroprevalence studies in
humans and wildlife.
Evaluate surveillance systems in
humans and wildlife.





filter paper blood collection
systems for antibody detection.
Role of marine Brucella in human
and wildlife disease.
Surveillance for disease in humans
and wildlife.
Marine Brucella species specific
antibody assay.
Toxoplasma Recent baseline levels of infection
and disease in humans and wildlife
unknown. Not a notifiable disease.
Conduct seroprevalence studies in
humans and wildlife.
Evaluate surveillance systems in
humans and wildlife.
Development/validation of field
filter paper blood collection
systems for antibody detection.
Role of predator prey cycles as a
mechanism of maintenance in
Arctic regions.
Trichinella Recent baseline levels of infection
and disease in humans and wildlife
unknown.
Conduct seroprevalence studies in
humans and wildlife.
Evaluate surveillance systems in
humans and wildlife.
Development/validation of field filter
paper blood collection systems for
antibody detection. Animal species
specific antibody assays.
Giardia/Cryptosporidium Recent baseline levels of infection
and disease in humans and wildlife
unknown (Underreported).




Significance of molecular variation
of strains and relationship to
disease in humans and wildlife.
Echinococcus Recent baseline levels of infection
and disease in humans and wildlife
unknown.




tests for diagnostics and
seroprevalence.
Significance of molecular variation
of strains and relationship to
disease in humans and wildlife.
Status of dog treatment
programmes unknown.
Assessment of dog treatment
programmes.
Rabies Prevalence in wildlife reservoirs
unknown.
No systematic surveillance in fox
populations.
Ecology and interaction between
Red and Arctic fox unknown.
Role of climate change on disease




Tularemia Recent baseline levels of infection
and disease in humans and wildlife
unknown.
Evaluate surveillance systems in
humans and wildlife.
All Agents Inconsistent disease awareness
and potential role of climate
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The most likely effect of climate change on the
transmission of tularemia in Alaska will be the impact
of climate on the distribution and abundance of tick
vectors and their respective rodent reservoirs. In Alaska,
the tree line is moving northward together with beaver,
muskrat and other rodent populations, potentially ex-
posing human residents of these regions to new diseases
such as tularemia (41).
Conclusions and recommended actions
The increasing ambient temperature in Alaska and other
regions of the Arctic may influence the incidence and
distribution of zoonotic and parasitic infections in hu-
mans by changing the population density and range of
wild and domestic animals and insect hosts. The public
health response should include enhancing the capacity
to monitor those potentially climate-sensitive infections
that are most likely to have a large public health impact;
investigating promptly infectious disease outbreaks that
may be related to climate change; and conducting re-
search into the relationship between climate and infec-
tious disease emergence to guide early detection and
public health interventions (58). The response should
also include a communication strategy to educate human
and animal health care providers emphasising the need
for complete surveillance reporting (59,60). The commu-
nication strategy should include education of the general
public, at risk sub-populations (hunters, trappers, sub-
sistence users wildlife biologists, livestock farmers pet
owners). At particular risk are Alaska Natives who often
depend on land and sea mammals to provide a healthy
affordable sustainable and culturally meaningful diet.
However, such a diet may place people at risk of
acquiring a zoonotic disease. For example, much of the
sea and land mammals that are consumed by Alaska
Natives are dried or eaten raw after freezing. While this is
an economical and efficient way to prepare meat preser-
ving both nutritionally and culturally, such methods of
food preparation may carry more risk for acquiring a
zoonotic disease than cooking the meat.
In Alaska, for these potentially climate sensitive
pathogens, the gaps in knowledge and solutions for
each pathogen tend to be similar (Table I). Surveillance
for infection and disease caused by many of these
pathogens in both humans and animals is incomplete.
It is not clear whether this is because of under reporting
or under diagnosis due to a lack of adequate diagnostics,
staffing issues in remote locations and logistical difficul-
ties associated with remote specimen collection and
shipping. Surveillance evaluations for zoonotic infections
all of which are potentially climate sensitive infections
are needed. As part of a strategy to improve reporting
to SOE and OSV, education materials should be devel-
oped and distributed to medical providers and labora-
tories emphasising the importance of complete sur-
veillance and reporting.
The challenge in Alaska will be to ensure sufficient
public health capacity to allow the detection of disease
outbreaks and to monitor infectious disease trends most
likely influenced by climate. Much can be learned about
the relationship between climate and weather and in-
fectious disease emergence by promptly reporting food
and water borne outbreaks that may be climate or
weather related allowing for appropriate preventive
measures to be implemented (61). However, additional
resources and training may be needed to ensure adequate
numbers of trained staff are available to address the
emerging public and wildlife health impacts posed by
climate change.
Baseline levels of infection in humans and animals
are unknown. In Alaska, there is the Alaska Area
Specimen Bank, which is a large collection of biologic
specimens (mostly sera) collected by public health agen-
cies since 1967. This collection can be used to determine
the seroprevalence of infectious diseases of concern
(62). Pilot seroprevalence studies are underway in selected
communities to determine the baseline seroprevalence
of Brucella, Fransicella, Toxoplasma, Trichinella, Giardia,
Cryptosporidium and Echinococcus. Similar studies, using
previously collected banked specimens need to be con-
ducted in appropriate wildlife species.
There is a need to improve diagnostics. Current
serologic tests for many pathogens of concern are not
species-specific and often cross-react with other bacte-
ria complicating their interpretation and hindering our
understanding of their ecology in nature. Efforts are
underway to establish and validate simple filter paper
blood collection systems that can be used by hunters
in the field. Such samples could be used for the detection
of antibodies using serologic methods and pathogen
Table 1 (Continued )
Agent Gaps Actions Needed Technology Needed
Inconsistent communication,
collaboration between subject
matter experts at federal, non-
federal agencies, institutes and
organisations.
Convene a working group to
provide communication, monitor
activities, actions needed and
progress.
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specific DNA by molecular methods. DNA sequencing
methods allows for the detection of molecular variation
among pathogen strains suggesting that certain assem-
blages are more likely to be associated with specific
animal species, i.e. parasites found in humans are more
likely to align with assemblages consisting of isolates
from other humans, as opposed to parasites from non-
human animal species. These methods could greatly
increase our understanding of disease ecology of these
pathogens in humans and animals living in Alaska.
More research is needed not only to understand the
disease ecology of these and other emerging pathogens
in humans and animals living in Alaska, but also to
understand the impact of climate change on disease
occurrence in humans and wildlife.
Ecosystem health, wildlife health and human health
are interconnected and there is a need to develop a
coordinated plan to monitor projects and activities that
focus on the impact of climate change on zoonotic and
parasitic infections in Alaska. This can be facilitated by
forming a working group that would include representa-
tion from State of Alaska Departments of Health and
Social Services, Environmental Conservation and Fish
& Game; Alaska Native Tribal Health Consortium,
University of Alaska, the CDC’s Arctic Investigations
Program, the US Fish & Wildlife Service and others to
monitor activities and ensure coordination and sample
sharing between appropriate agencies, institutes and
organisations.
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